Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of adding nintedanib to a prednisone taper for radiation pneumonitis; results have been posted after completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lung Metastases
• Radiation Pneumonitis

Drugs mentioned

• OFEV (Nintedanib)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer, Lung Metastases | Phase 2 | Status: COMPLETED | Results posted: 2025-04-16